Help For Irritable Bowel Syndrome (IBS) - Education, Support, & Self Help for Irritable Bowel Syndrome   
Heather & Company View Cart  
Shop for IBSIBS Message BoardsIBS News & ReviewsStore Finder  
Home
IBS Diet & Recipes
IBS Books
IBS Supplements
Yoga for IBS
Hypnosis for IBS
Tummy Teas

All Boards >> Irritable Bowel Syndrome Research Library

HeatherAdministrator

Reged: 12/09/02
Posts: 7405
Loc: Seattle, WA
Pipeline Treatments, Novel Procedures Offer New Options for GI Diseases
      06/04/04 06:41 PM

CONTACT: Tuesday, May 18, 3:00 pm CDT Kellie Hanzak, 202-955-6222 khanzak@spectrumscience.com Jessica Willocks, 301-941-2625 jwillocks@gastro.org

In New Orleans: Morial Convention Center 504-670-6420

RESEARCH HONES IN ON THERAPIES AND DIAGNOSIS OF BOWEL DISEASES

Pipeline Treatments, Novel Procedures Offer New Options for GI Diseases

New Orleans, LA – Inflammatory bowel diseases collectively cause significant lifestyle sacrifices and suffering and millions of dollars in related health care costs every year, partially due to a lack of effective diagnostic procedures and therapies. In new studies presented today at Digestive Disease Week in New Orleans, researchers show evidence of accurate and effective new methods for diagnosis, as well as improved treatment options, for sufferers of ulcerative colitis and Crohn’s diseases.

Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

“We are pleased to see more attention directed toward improving the lives of people suffering from inflammatory bowel diseases,” said Jim Lewis, M.D., of the University of Pennsylvania. “For too long, the rate of discovery was slow. Now we are seeing more answers for the millions of sufferers.”

Capsule Endoscopy in IBD: Findings and Effects on Clinical Outcomes (Abstract 105669*)

The M2A video capsule or “camera pill” allows gastroenterologists their best view yet of the small bowel, assisting in the diagnosis of inflammatory bowel disease. Until now, studies have not analyzed the influence of capsule endoscopy on clinical decision-making and therapeutic outcomes in IBD.

According to research presented by scientists from Mount Sinai Medical Center, use of the video capsule improves clinical outcomes significantly.

2 – 2 – 2 Bowel Diseases

For the study, the team of researchers reviewed the results of capsule endoscopy in patients with IBD-related indications. A total of 65 patients met the inclusion criteria and fit in four categories: A) abnormal small bowel series, rule out Crohn’s Disease (CD); B) abdominal pain, normal radiologic studies, rule out CD; C) known ulcerative or Crohn’s colitis; normal small bowel series and persistent symptoms, rule out small bowel disease; and D) known CD, with persistent obscure bleeding.

Overall, for 20 of the 21 patients (95 percent) in whom major diagnostic findings were discovered using capsule endoscopy, therapeutic decisions based on the results led to clinical improvement in patient outcome. In groups A and B, an absence of small bowel findings in 30 of 32 patients helped rule out CD. Throughout an average follow-up of 19 months, no evidence of CD developed, leading to a negative predictive value for the capsule study of 100 percent in this setting. In groups C and D, researchers discovered positive diagnostic findings on capsule endoscopy in 18 of 33 patients.

“Based on our research, we believe that capsule endoscopy may play an important role in clinical diagnosis and therapeutic decisions in patients with IBD indications,” said Peter Legnani, M.D., lead author of the study. “We hope that the ease of use of the capsule may encourage more patients to undergo screening to confirm diagnosis of IBD and receive appropriate treatment.”

Basiliximab (anti-CD25) for the Treatment of Steroid Resistant Ulcerative Colitis (Abstract 104640*)

Steroid therapy is one of the most effective treatments for ulcerative colitis (UC), which causes inflammation and ulcers in the lining of the large intestine, but up to 30 percent of patients will have a poor response to steroids. These steroid-resistant individuals present a difficult clinical challenge to gastroenterologists, because few treatment options exist after steroids other than removal of the entire colon (colectomy).

Basiliximab (Simulect®), a novel monoclonal antibody, has potential as a new treatment option, according to research from Henry Wellcome Laboratories at the University of Bristol in England.

3 – 3 – 3 Bowel Diseases

Basiliximab has been proven effective as a steroid sensitizer in steroid resistant UC both in the lab and in humans. This uncontrolled pilot study examined an extended series of 30 steroid resistant UC patients treated with basiliximab. Twenty patients with moderately active disease and 10 patients with severe disease were treated with a single intravenous (IV) dose of basiliximab (40 mg) in addition to their standard steroid therapy to monitor for remission within eight weeks, defined by an Ulcerative Colitis Symptom Score (UCSS) of less than two.

A total of 24 out of the 30 patients (80%) improved their UCSS score, with 19 of 30 (63%) achieving full remission. In the moderate disease group, 14 of 20 patients (70%) achieved full remission, and an additional five of 20 (25%) showed an improvement. In the severe disease group, five of the 10 patients (50%) achieved remission, while five required colectomy. There were no infusion reactions.

“These studies show that the use of basiliximab can provide significant improvements or remission for patients with ulcerative colitis,” said Tom Creed, M.D., lead author of the study. “We hope that a larger, controlled trial will confirm these results and help make this potentially valuable therapy available to patients who can benefit from it.”

Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Safety and Efficacy Trial of Once-Daily, Oral OPC-6535 in the Treatment of Active Ulcerative Colitis (Abstract 105516*)

For patients suffering from severe ulcerative colitis (UC), new treatments that are safe and have minimal side effects are desperately needed. In this randomized study, researchers at the University of Chicago examined the effectiveness and tolerability of the compound OPC-6535 to treat UC. OPC-6535 was administered orally in a once-daily 25 mg or 50 mg dose to subjects with a new or established diagnosis of UC, flare within 12 weeks, and Disease Activity Index (DAI) of four to 11 on a scale of 12. A total of 186 patients were given either OPC-6535 or placebo for eight weeks. Patients were permitted to take 5-ASA (aminosalicylic acid) if they were stable for 14 days before entry and subsequent study duration (approximately 75% of subjects); 5-ASA is a standard treatment for UC.

4 – 4 – 4 Bowel Diseases

ore than half (55%) of the 25 mg group and 48 percent of the 50 mg group showed clinical improvement. The average change in DAI was significantly greater in the 25 mg group and was nearly statistically significant in the 50 mg OPC-6535 group versus placebo. Improvement in physician global assessment was more noticeable in the 50 mg dosage group, as a significantly higher proportion of these patients achieved remission (DAI 0-1) compared to the other treatment groups.

Responses were uniformly greater in the subgroup of patients with more severe disease. No differences were observed between 5-ASA users and non-users. “Based on these results, we are confident that OPC-6535 could be an effective treatment option for patients with ulcerative colitis, particularly in those with moderately severe disease,” said Stephen Hanauer, M.D., lead author of the study.

“Further clinical studies are needed to confirm the best dose, but we were pleased to see a positive response to higher doses, as the efficacy may be even greater.” ### Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 15-20, 2004 in New Orleans, Louisiana. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. *Abstract numbers listed above correlate to abstract ID numbers listed on the DDW Web site, www.ddw.org. They do not coincide with program numbers as found in the printed DDW Program Guide.

http://www.ddw.org/media/newsReleases/IBDTherapies.pdf

--------------------
Heather is the Administrator of the IBS Message Boards. She’s the author of Eating for IBS and The First Year: IBS, and the CEO of Heather's Tummy Care. Join her IBS Newsletter. Meet Heather on Facebook!

Post Extras Print Post   Remind Me!     Notify Moderator

Entire thread
Subject Posted by Posted on
* Inflammatory Bowel Disease HeatherAdministrator 07/14/03 01:51 PM
. * Hormonal contraception improved menstrual-related IBD symptoms HeatherAdministrator   09/15/14 12:43 PM
. * Fecal lactoferrin differentiated IBD from IBS HeatherAdministrator   07/29/14 01:50 PM
. * Vitamin D and Cancer Risk in IBD HeatherAdministrator   07/15/14 02:53 PM
. * Self-assessment scale developed for patients with IBD-fatigue HeatherAdministrator   06/17/14 10:44 AM
. * Stool test distinguishes between IBD and IBS HeatherAdministrator   04/07/14 01:40 PM
. * Breathing exercises, meditation improved inflammatory markers, quality of life in IBD patients HeatherAdministrator   10/23/13 04:20 PM
. * Inflammatory Bowel Disease: Heat Waves Linked to Flares HeatherAdministrator   08/16/13 12:58 PM
. * Dietary changes may reduce effects of IBD HeatherAdministrator   06/27/13 05:43 PM
. * Genetic Clues May Help Unravel Cause of Crohn's HeatherAdministrator   11/02/12 12:59 PM
. * Inflammatory bowel, ulcerative colitis linked to intestinal fungi HeatherAdministrator   06/15/12 01:23 PM
. * Smoking makes Crohn's disease worse HeatherAdministrator   05/09/12 01:33 PM
. * Kids With Crohn’s Disease, Colitis Often Struggle at School HeatherAdministrator   04/23/12 01:22 PM
. * As Nations Develop, So May Bowel Disease HeatherAdministrator   01/09/12 12:01 PM
. * Loneliness Triggers Inflammatory Illnesses HeatherAdministrator   02/10/11 10:05 AM
. * Infants' antibiotic use tied to IBD risk HeatherAdministrator   11/03/10 01:42 PM
. * Olive Oil May Protect Against Ulcerative Colitis HeatherAdministrator   05/05/10 10:32 AM
. * Accutane may cause ulcerative colitis HeatherAdministrator   04/09/10 01:38 PM
. * Red meat may raise odds for ulcerative colitis, but oily fish could be protective HeatherAdministrator   03/11/10 01:22 PM
. * Inflammatory Bowel Disease and Irritable Bowel Syndrome: Separate or Unified? HeatherAdministrator   01/05/10 12:03 PM
. * Novel Compound Targets Mucosal Healing in Crohn's HeatherAdministrator   05/29/06 02:19 PM
. * Viagra May Help Crohn's Disease HeatherAdministrator   03/04/06 12:50 PM
. * Carbon Monoxide Eases Ulcerative Colitis HeatherAdministrator   01/18/06 04:12 PM
. * Colonoscopic Surveillance in Inflammatory Bowel Disease HeatherAdministrator   10/11/05 01:33 PM
. * Oral Contraceptives and HRT a Risk Factor for Inflammatory Bowel Disease HeatherAdministrator   09/13/05 01:22 PM
. * Cannabinoids Show Promise for Inflammatory Bowel Disease HeatherAdministrator   09/01/05 11:23 AM
. * Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome HeatherAdministrator   09/01/05 11:13 AM
. * The Clinical Epidemiology of Inflammatory Bowel Disease HeatherAdministrator   08/22/05 04:45 PM
. * IBD Patients May Benefit From Folic Acid Supplementation HeatherAdministrator   05/22/05 07:02 PM
. * Fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis HeatherAdministrator   04/24/05 03:33 PM
. * Biotic Therapy Cuts Inflammation in Ulcerative Colitis HeatherAdministrator   02/19/05 05:59 PM
. * Calming Crohn's Disease with Fish Oil and Antioxidants HeatherAdministrator   01/07/05 04:55 PM
. * Probiotics Prove Just As Effective As a Popular Prescription Drug for Ulcerative Colitis HeatherAdministrator   12/20/04 01:37 PM
. * Increased Incidence of Inflammatory Bowel Disease: The Price of the Decline of Infectious Burden? HeatherAdministrator   11/28/04 02:58 PM
. * Diet May Influence Relapse in Ulcerative Colitis HeatherAdministrator   10/24/04 07:50 PM
. * Parasite Therapy for Crohn's and Colitis? HeatherAdministrator   08/08/04 03:00 PM
. * Pipeline Treatments, Novel Procedures Offer New Options for GI Diseases HeatherAdministrator   06/04/04 06:41 PM
. * Faulty Gene for Crohn's Disease Found HeatherAdministrator   04/13/04 03:19 PM
. * Data links Crohn's disease and antibiotics HeatherAdministrator   02/24/04 02:07 PM
. * Elan Reports Successful Results of Antegren Trial for Crohn's Disease HeatherAdministrator   02/10/04 01:30 PM
. * 5-ASA Therapy for Inflammatory Bowel Disease No Bar to Colon Cancer HeatherAdministrator   02/10/04 01:29 PM
. * Once-Daily Probiotic Treatment Maintains Remission in Ulcerative Colitis patients with Pouchitis HeatherAdministrator   01/26/04 03:33 PM
. * Bone Disease and Intestinal Problems May Share a Common Cause HeatherAdministrator   01/07/04 11:47 AM
. * Increased Anal Resting Pressure and Rectal Sensitivity in Crohn's Disease HeatherAdministrator   12/16/03 11:59 AM
. * Environmental Factors May Play a Role in the Pathogenesis of IBD HeatherAdministrator   12/01/03 05:56 PM
. * Colonoscopy Prep HeatherAdministrator   10/17/03 12:05 PM
. * Detection of Pulmonary Involvement in Inflammatory Bowel Disease HeatherAdministrator   09/30/03 01:20 PM
. * Indeterminate Colitis HeatherAdministrator   09/16/03 03:33 PM
. * Familial Occurrence of Inflammatory Bowel Disease in Celiac Disease HeatherAdministrator   09/16/03 03:30 PM
. * Bacteria in Milk Linked to Crohn's Disease and Possibly IBS HeatherAdministrator   08/12/03 11:55 AM
. * Inflammatory Bowel Disease During Pregnancy. HeatherAdministrator   07/15/03 06:20 PM
. * A study of the menopause, smoking, and contraception in women with Crohn's disease. HeatherAdministrator   07/15/03 06:05 PM
. * Hormone replacement therapy prevents bone loss in patients with IBD HeatherAdministrator   07/15/03 06:02 PM
. * Chemo Drug Improves Crohn's Symptoms HeatherAdministrator   07/14/03 04:09 PM

Extra information
0 registered and 0 anonymous users are browsing this forum.

Moderator:  Heather 



Permissions
      You cannot post until you login
      You cannot reply until you login
      HTML is enabled
      UBBCode is enabled

Thread views: 146054

Jump to

| Privacy statement Help for IBS Home

*
UBB.threads™ 6.2



LEGAL DISCLAIMER - This website is not intended to replace the services of a physician, nor does it constitute a doctor-patient relationship. Information on this web site is provided for informational purposes only and is not a substitute for professional medical advice. You should not use the information on this web site for diagnosing or treating a medical or health condition. If you have or suspect you have an urgent medical problem, promptly contact your professional healthcare provider.

Any application of the recommendations in this website is at the reader's discretion. Heather Van Vorous, HelpForIBS.com, and Heather & Company for IBS, LLC are not liable for any direct or indirect claim, loss or damage resulting from use of this website and/or any web site(s) linked to/from it. Readers should consult their own physicians concerning the recommendations on these message boards.



Home | Shop for IBS | IBS Message Boards | IBS News & Reviews | IBS Support Groups
IBS Diet & Recipes | IBS Books | IBS Supplements | Yoga for IBS | Hypnosis for IBS
IBS Tummy Teas™ | Irritable Bowel Syndrome Glossary

About Us | IBS Links | Search this Site | Site Map | Shipping & Returns | Privacy & Security
Contact Us | For Doctors & Dietitians | Wholesale | Co-packing Services

© 1999-2009, Heather Van Vorous, HelpForIBS.com, Heather & Company for IBS, LLC.
All information & art is proprietary and may not be duplicated.
All rights reserved.

Legal & Medical Disclaimer

Website Design